PainAway II Acetaminophen/Aspirin/Caffeine Tablets Recalled for Failed Stability
Ultra Seal Corporation is recalling PainAway II tablets nationwide due to failed stability specifications. Testing found out-of-specification levels of Salicylic Acid, an aspirin-related compound.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall involving a labeling/quality issue (failed stability specifications) with no reported illnesses or injuries. The hazard is based on out-of-specification test results rather than confirmed harm or a high-risk pathogen, placing it in the Moderate category per the rubric.
Plain-English summary
Ultra Seal Corporation is recalling PainAway II (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets distributed nationwide in the USA. The recall affects 2,484,274 tablets packaged in 2 tablets per packet within 12,000 packets per case (Material # 11161), manufactured for Respond Industries First Aid in Mason, Ohio.
The recall was initiated because stability testing revealed out-of-specification results for Salicylic Acid, an aspirin-related compound. This indicates the product did not meet required stability specifications.
Affected lot numbers include: AK-9336 (expiration 21-Oct); K9406 and AK-9407 (expiration 21-Dec); K-9860 (expiration 22-Oct); and AK-1057 (expiration 23-Feb). Consumers who have purchased this product should stop use and consult their healthcare provider if they have questions or concerns.
The recalled product
- Product
- PainAway II (Acetaminophen 250 mg/Aspirin 250 mg/Caffeine 65 mg) tablets , 2 tablets/pk, packaged in 12,000 Packets/Case, Material # 11161, Mfg. for Respond Industries First Aid, Mason, OH 45040 (Shipping Label)
- Manufacturer
- Ultra Seal Corporation
- Hazard
- failed-stability-specifications
- out-of-specification-aspirin-related-compound
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot #: AK-9336
- exp. date 21-Oct
- K9406
- AK-9407
- exp. date 21-Dec
- K-9860
- exp. date 22-Oct
- AK-1057
- exp. date 23-Feb
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27